lobbying_activities: 959042

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
959042	b32294fd-a7ed-49e7-8977-f2b61409eac4	Q2	THE PETRIZZO GROUP, INC.	305932	FATE THERAPEUTICS, INC.	2010	second_quarter	MED	Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.	HOUSE OF REPRESENTATIVES,SENATE	25000		0	0	2010-07-17T14:29:59.563000-04:00